New ETEC vaccine technology targeting enterotoxigenic Escherichia coli has been licensed to Valneva after decades of research at University of Bergen.
A decades-long effort to develop a vaccine against one of the world's leading causes of severe digestive illness has reached a milestone, according to new research.
Scientists recently developed a t… [+2726 chars]
Scientists recently developed a t… [+2726 chars]